A detailed history of Pathstone Holdings, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 27,022 shares of LNTH stock, worth $2.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,022
Previous 22,728 18.89%
Holding current value
$2.47 Million
Previous $1.82 Million 62.55%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$77.7 - $123.62 $333,643 - $530,824
4,294 Added 18.89%
27,022 $2.97 Million
Q2 2024

Aug 14, 2024

BUY
$58.87 - $83.05 $185,617 - $261,856
3,153 Added 16.11%
22,728 $1.82 Million
Q1 2024

May 13, 2024

BUY
$51.07 - $68.26 $384,914 - $514,475
7,537 Added 62.61%
19,575 $1.22 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $669,312 - $937,639
12,038 New
12,038 $746,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.28B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.